Início › Câncer de Mama › Connecticut

Ensaios clínicos de Câncer de Mama em Connecticut

46 estudos para Câncer de Mama estão buscando participantes em locais em Connecticut.

Cidades em Connecticut

Texto oficial do estudo (Inglês)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Yale Cancer Center, New Haven

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Yale Cancer Center, New Haven

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06172478

A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer

Yale University School of Medicine - Yale Cancer Center, New Haven

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07701941

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Yale University School of Medicine, New Haven

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06324357

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Yale University - Yale University School of Medicine, New Haven

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07360314

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

Yale Cancer Center, New Haven

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07578571

Study of AVZO-021 in Patients With Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site, New Haven

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05867251

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

Yale Cancer Center, New Haven

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07222267

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Yale Cancer Center ( Site 0060), New Haven
Stamford Hospital ( Site 0049), Stamford

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06312176

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Smilow Cancer Hospital Care Center - Derby, Derby
Smilow Cancer Hospital Care Center - Fairfield, Fairfield
Smilow Cancer Hospital at Glastonbury, Glastonbury
e mais 10

RecrutandoFase 3

Idades 60 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06377852

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, New Haven

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06103864

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

Kivu Trial Site, New Have

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT07229313

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, New Haven

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07085767

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Hartford Healthcare Institute, Hartford
Yale Cancer Center, New Haven

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07214532

A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer

Yale University School Of Medicine, New Haven

RecrutandoFase 1

Idades 18 e acima · Mulheres · Atualizado em 21 de set. de 2026 · NCT07524855

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

Norwalk Hospital, Norwalk

RecrutandoFase 2

Idades 45 e acima · Mulheres · Atualizado em 21 de set. de 2026 · NCT04084730

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Yale Cancer Center Clinical Trials Office, New Haven

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT07340541

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Yale New Haven Hospital- Yale Cancer Center, New Haven

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT06492616

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

Yale Cancer Center, New Haven

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT05315700

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Yale-New Haven Hospital-Yale Cancer Center, New Haven

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06982521

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Hartford HealthCare - Avon, Avon
Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
Danbury Hospital, Danbury
e mais 19

RecrutandoFase 3

Idades de 18 a 60 · Mulheres · Atualizado em 2 de set. de 2026 · NCT05879926

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Smilow Cancer Hospital at Yale New Haven, New Haven

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06072612

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Yale Cancer Center, New Haven

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 28 de ago. de 2026 · NCT07029399

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

Yale University Cancer Center, New Haven

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT06533826

Optimizing Surgical Decisions in Young Adults With Breast Cancer

Yale Cancer Center, New Haven

Recrutando

Idades de 18 a 44 · Mulheres · Atualizado em 19 de ago. de 2026 · NCT06275126

ATEMPT 2.0: Adjuvant T-DM1 vs TH

Smilow Cancer Hospital Care center at Derby, Derby
Smilow Cancer Hospital Care center at Fairfield, Fairfield
Smilow Cancer Hospital Care center at Glastonbury, Glastonbury
e mais 11

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT04893109

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Yale Cancer Center - Smilow Cancer Hospital, New Haven

RecrutandoFase 3

Idades de 18 a 100 · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT05232916

E-Mindfulness Approaches for Living After Breast Cancer

Stamford Hospital/Bennett Cancer Center, Stamford

RecrutandoFase 3

Idades de 18 a 50 · Todos os sexos · Atualizado em 4 de ago. de 2026 · NCT06748222

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Norwalk Hospital, Norwalk

RecrutandoFase 2

Idades 8 e acima · Todos os sexos · Atualizado em 27 de jul. de 2026 · NCT05503797

Pre-Operative Window of ET to Inform RT Decisions (POWER II)

Yale University, New Haven

RecrutandoFase 3

Idades 65 e acima · Mulheres · Atualizado em 30 de jun. de 2026 · NCT06507618

Integrated Cancer Repository for Cancer Research

Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

Yale University, Yale Cancer Center, New Haven

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 23 de jun. de 2026 · NCT06993844

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy

Yale Cancer Center Smilow Cancer Hospital, New Haven

RecrutandoFase 1

Idades 18 e acima · Mulheres · Atualizado em 22 de mai. de 2026 · NCT05989347

Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns

Yale Cancer Center, New Haven

RecrutandoEstudo observacional

Idades de 18 a 80 · Mulheres · Atualizado em 22 de mai. de 2026 · NCT06551220

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Smilow Cancer Hospital - Derby, Derby
Smilow Cancer Hospital - Fairfield, Fairfield
Smilow Cancer Hospital - Glastonbury, Glastonbury
e mais 7

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 6 de mai. de 2026 · NCT07062965

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Yale Cancer Center, New Haven

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 6 de mai. de 2026 · NCT01042379

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Stamford Hospital, Stamford

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 29 de abr. de 2026 · NCT04468061

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Smilow Cancer Hospital-Derby Care Center, Derby
Smilow Cancer Hospital Care Center-Fairfield, Fairfield
Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury
e mais 13

RecrutandoFase 3

Idades de 50 a 70 · Todos os sexos · Atualizado em 23 de abr. de 2026 · NCT04852887

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Yale University, Yale Cancer Center, New Haven

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 27 de mar. de 2026 · NCT06395519

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Hartford Healthcare, Hartford
WCHN Norwalk Hospital - Data Collection, Norwalk

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 27 de fev. de 2026 · NCT03808337

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.